This suggests that increased levels of STING and IFNβ may contribute to innate immune activation leading to improved outcomes for patients with HNSCC, correlating with evidence that elevated STING expression enhances responses to radiation treatments (69). This evidence concerns the gene STING1 and head and neck squamous cell carcinoma.